Preliminary evidence that hydroxyurea is associated with attenuated peripheral sensitization in adults with sickle cell disease

INTRODUCTION: Hydroxyurea (HU) is a drug that targets the underlying pathophysiology of sickle cell disease (SCD); however, it continues to be an underutilized treatment for adults. Previous research suggests that HU treatment can result in fewer hospital contacts for acute vaso-occlusive pain crise...

Descripción completa

Detalles Bibliográficos
Autores principales: Letzen, Janelle E., Lanzkron, Sophie, Bond, Kasey, Carroll, Christopher Patrick, Haythornthwaite, Jennifer A., Nance, Sabrina, Campbell, Claudia M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2019
Materias:
General Section
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6455681/
https://www.ncbi.nlm.nih.gov/pubmed/31041423
http://dx.doi.org/10.1097/PR9.0000000000000724

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6455681/
https://www.ncbi.nlm.nih.gov/pubmed/31041423
http://dx.doi.org/10.1097/PR9.0000000000000724

Ejemplares similares